References

1. Strausberg RL, Simpson AJG, Wooster R. Sequence-based cancer genomics: progress, lessons and opportunities. Nature Rev/Genetics 2003; 4:409-418.

2. Chanda SK, Caldwell JS. Fulfilling the promise: drug discovery in the post-genomic era. DDT 2003; 8: 168-174.

3. Balleine RL, Kefford RF. Targeting molecular mechanisms in cancer. ANZ J Surg 2002; 72:760-763.

4. Rosell R, Monzo M, O'Brate A, Taron M. Translational oncogenomics: toward rational therpeutic decision-making. Curr Opin Oncol 2002; 14:171-179.

5. Baak JPA, Path FRC, Hermsen MAJA, Meijer G, Schmidt J, Janssen EAM. Genomics and proteomics in cancer. Eur J Cancer 2003; 39:1199-1215.

6. Strausberg RL, Austin MJF. Functional genomics: technological challenges and opportunities. Physiol Genom 1999; 1:25-32.

7. Strong LC. Genetic nature of the constitutional states of cancer susceptibility and resistance in mice and men. Yale J Biol Med 2000; 73:265-272. (Originally published: 1945; 17:289-299).

8. Largaespada DA. Genetically modified mice in cancer research. In: Hofker LMH, van Deursen J, eds. Transgenic mouse methods and protocols. Totowa, NJ: Humana, 2002:311-332.

9. Choy G, Choyke P, Libutti SK. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2003; 2(4):303-312.

10. Choy G, O'Connor S, Diehn FE, Costouros N, Alexander HR, Choyke P, et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. BioTechniques 2003; 35:1022-1030.

11. Contag PR. Whole-animal cellular and molecular imaging to accelerate drug development. DDT 2002; 7:10:555-562.

12. McCaffrey A, Kay MA, Contag CH. Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging 2003; 2(2):75-86.

13. Contag CH, Jenkins E, Contag PR, Negrin RS. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2(1-2):41-52.

14. Jenkins DE, Oei Y, Hornig YS, Yu S-F, Dusich J, Purchio R, et al. Bioluinescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 2003; 20:733-744.

15. Jenkins DE, Yu S-F, Hornig YS, Purchio T, Contag PR. In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 2003; 20:745-756.

16. Sweeney TJ, Mailander V, Tucker AA, Olomu AB, Zhang W, Cao Y, et al. Visualizing the kinetics of tumor-cell clearance in living animals. PNAS 1999; 96(21):12,044-12,049.

17. Wang W, El-Deiry WS. Bioluminescent molecular imaging of endogenous and exogenous p53-medi-ated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther 2003; 2(2):196-202.

18. Zhang W, Purchio AF, Coffee R, West DB. Differential regulation of the human Cyp3a4 promoter in transgenic mice and rats. Drug Metab Dispos 2004; 32:2:163-167.

19. Zhang N, Fang Z, Contag PR, Purchio AF, West DB. Using a Vegfr2-luciferase transgenic mouse. Blood 2004; 103(2):617-626.

20. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 2002; 62:1862-1867.

21. Safran M, Kim WY, Kung AL, Horner JW, DePinho, Kaelin WG Jr. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone cre-mediated recombination. Mol Imaging 2003; 2:297-302.

22. Lyons SK, Meuwissen R, Krimpenfort P, Berns A. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003; 63:70427046.

23. Gabrielson E, Berg K, Ramaswamy A. Functional genomics, gene arrays, and the future of pathology. Mod Pathol 2001; 14(12):1294-1299.

24. Weber BL. Cancer genomics. Cancer Cell 2002; 1:37.

0 0

Post a comment